Vantage Market Research.png
Global Vein Illuminator Market to Reach USD 327.2 Million by 2028 - Rising Demand of Vein Illuminator from Hospitals to Boost Market - Exclusive Report by Vantage Market Research
January 31, 2022 06:33 ET | Vantage Market Research
WASHINGTON, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Vein Illuminator Market finds that mounting demand of Vein Illuminator from hospitals is...
MOFFITT_LOGO-preferred2color.jpg
Moffitt Cancer Center Advances Patient Standard of Care by Introducing Needleless Blood Draws
March 24, 2021 10:00 ET | Moffitt Cancer Center
TAMPA, Fla., March 24, 2021 (GLOBE NEWSWIRE) -- Moffitt Cancer Center has adopted a new needle-free method of blood collection for patients in treatment who often need to undergo repeated needle...
HolyNameMedicalCenterLogoStacked3.jpg
Holy Name Medical Center Launches One-Stick Hospitalization as New Inpatient Standard of Care
February 11, 2021 08:00 ET | Holy Name Medical Center
TEANECK, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Holy Name Medical Center today announced that it is the first hospital in New Jersey among a growing number of health systems nationwide to offer...
58437_VVlogopngcopy.jpg
Velano Vascular Named Top Impact Company for 2021 by Real Leaders
January 13, 2021 09:00 ET | Velano Vascular
Velano recognized for pioneering a more humane standard of care for hospital patients; follows on heels of being named fastest growing medical device company in the U.S. and one of world’s most...
58437_VVlogopngcopy.jpg
Velano Secures Additional Funding to Meet Commercial Demand for PIVO, Fueled by Industry Move to One-Stick Hospitalization
December 17, 2019 07:00 ET | Velano Vascular
- Latest funding caps year of groundbreaking milestones for transformative vascular access company; new capital will be used to meet rapidly growing hospital and patient demand - SAN FRANCISCO, Dec. ...
58437_VVlogopngcopy.jpg
Velano Vascular Receives Frost & Sullivan’s 2019 North America Product Leadership Award for Needle-free Venous Access Technology
November 20, 2019 08:00 ET | Velano Vascular
SAN FRANCISCO, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Vascular access technology pioneer Velano Vascular today announced that it has been named the Frost & Sullivan 2019 North American Product...
58437_VVlogopngcopy.jpg
Velano Primes for Growth with Funding from Intermountain Healthcare and Notable Individual Investors to Transform Blood Collection Globally
May 08, 2019 07:00 ET | Velano Vascular
SAN FRANCISCO, May 08, 2019 (GLOBE NEWSWIRE) -- Vascular access technology pioneer Velano Vascular today announced that it has secured $10 million as the initial tranche of a growth financing to...
58437_VVlogopngcopy.jpg
Velano Named One of Fast Company’s 2019 Top Ten Most Innovative Companies in Biotech for Pioneering Better Blood Draws
February 20, 2019 10:06 ET | Velano Vascular
SAN FRANCISCO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Vascular access technology pioneer Velano Vascular has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies...
58437_VVlogopngcopy.jpg
Velano Adds to Leadership Team and Advisory Board to Accelerate Adoption of Novel Human-Centered Standard of Care for Inpatient Blood Draws 
December 05, 2018 08:00 ET | Velano Vascular
SAN FRANCISCO, Dec. 05, 2018 (GLOBE NEWSWIRE) -- Vascular access technology innovator Velano Vascular continues to aggressively expand in pursuit of its mission to dramatically remake blood...
58437_VVlogopngcopy.jpg
Velano Vascular Adds Healthcare Veterans David R. Strand and Dr. Gary Kurtzman to Board of Directors
August 01, 2018 08:00 ET | Velano Vascular
SAN FRANCISCO, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Vascular access technology innovator Velano Vascular today welcomed Safeguard Scientifics Healthcare Managing Director, Gary Kurtzman, MD and...